Page last updated: 2024-12-10

ly 303070

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GYKI 53784: a 2,3-benzodiazepine cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3074805
CHEMBL ID411664
SCHEMBL ID8192023
MeSH IDM0304003

Synonyms (24)

Synonym
gyki 53784
ly 303070
7h-1,3-dioxolo(4,5-h)(2,3)benzodiazepine-7-carboxamide, 8,9-dihydro-5-(4-aminophenyl)-n,8-dimethyl-, (r)-
CHEMBL411664
ly-303070
unii-91n8o25h4l
ly303070
bdz-f compound
161832-71-9
5-(4-aminophenyl)-8-methyl-7-(n-methylcarbamoyl)-8,9-dihydro-7h-1,3-dioxolo(4,5-h)(2,3)benzodiazepine
91n8o25h4l ,
gyki-53784
SCHEMBL8192023
ly-300168, (r)-
(-)-1-(4-aminophenyl)-3-methylcarbamoyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine
7h-1,3-dioxolo(4,5-h)(2,3)benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-n,8-dimethyl-, (8r)-
ly-300168, (-)-
DTXSID20167260
(8r)-5-(4-aminophenyl)-n,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide
Q27271412
(r)-ly-300168
(r)-5-(4-aminophenyl)-n,8-dimethyl-8,9-dihydro-7h-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepine-7-carboxamide
7h-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-n,8-dimethyl-, (8r)-
AKOS040751988
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID326374Inhibition of kainate-induced C57BL/6N mouse hippocampal neurons excitotoxicity after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (20.00)18.2507
2000's14 (70.00)29.6817
2010's2 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.21 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]